Trishizukaol A alleviates chronic kidney disease by restraining P2X7/PSME3-driven 20S proteasome hyperactivation
Bibliographic Data
| ID | 14745749 |
|---|---|
| Authors | Pengfei Tang (0000-0003-4145-6007, China Pharmaceutical University), Ze Zheng (0000-0002-6270-085X, China Pharmaceutical University), Mengmeng Yu (0000-0002-8049-3735, China Pharmaceutical University), Danyang Zhang (0000-0003-3863-2460, China Pharmaceutical University), Zhiqi Xiao (China Pharmaceutical University), Lingyi Kong (0000-0001-5519-1703, China Pharmaceutical University, corresponding author), Jun Luo (0000-0002-0006-7876, China Pharmaceutical University, corresponding author) |
| Year | 2026 |
| Volume | 362 |
| Pages | 121357 |
| Publication date | 2026-05-01 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2026.121357 |
| PMID | 41679361 |
| OpenAlex | W7128482788 |
| Language | EN |
| References cited | 43 |
Disease · Hyperactivation · Kidney · Kidney disease · Pathogenesis · Proteasome · Adenosine and Purinergic Signaling · Coenzyme Q10 studies and effects · Ubiquitin and proteasome pathways
| Highly cited | No |
|---|